SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12B-25
Commission File Number 333-62216
---------------------
NOTIFICATION OF LATE FILING
(Check One):
[ ] Form 10-KSB [ ] Form 20-F [ ]Form 11-K [X]Form 10-QSB [ ] Form N-SAR [ ] Form N-CSR
For Period Ended: June 30, 2007
------------------------------------------------------
[ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K
For the Transition Period Ended:__________________________
READ INSTRUCTION SHEET BEFORE PREPARING FORM. PLEASE PRINT OR TYPE.
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION
HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.
If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:
--------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
Full Name of Registrant: HEALTH DISCOVERY CORPORATION
--------------------------------------------------------
Former Name if Applicable:
-----------------------------------------------------
Address of Principal Executive Office
(STREET AND NUMBER): 2 East Bryan Street, Suite #601
-----------------------------------------------------------
City, State and Zip Code: Savannah, Georgia 31401
-----------------------------------------------------
PART II - RULE 12B-25(B) AND (C)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
| (a) The reason described in reasonable detail in Part III
| of this form could not be eliminated without
| unreasonable effort or expense;
|
[X] | (b) The subject annual report, semi-annual report,
| transition report on Form 10-K, Form 20-F, 11-K or
| Form N-SAR, or portion thereof will be filed on or
| before the 15th calendar day following the prescribed
| due date; or the subject quarterly report or
| transition report on Form 10-Q, or portion thereof
| will be filed on or before the fifth calendar day
| following the prescribed due date; and
|
| (c) The independent registered public accounting firm's
| statement or other exhibit required by Rule 12b-25(c)
| has been attached if applicable.
|
1
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 11-K,
20-F, 10-Q, N-SAR, N-CSR, or the transition report portion thereof, could not be
filed within the prescribed time period.
The Registrant could not complete its Quarterly Report on Form 10-QSB
for the quarter ended June 30, 2007 within the prescribed time because final
revisions to the Quarterly Report could not be processed by the 5:30
edgarization deadline.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
DANIEL R. FURTH (912) 443-1987
--------------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no,
identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
[ ] Yes [X] No
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
HEALTH DISCOVERY CORPORATION
-------------------------------------------
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: August 15, 2007 By: /S/ DANIEL R. FURTH
------------------------------ ------------------------------
Daniel R. Furth
Principal Financial Officer
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
GENERAL INSTRUCTIONS
1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
Rules and Regulations under the Securities Exchange Act of 1934.
2. One signed original and four conformed copies of this form and
amendments thereto must be completed and filed with the Securities and
Exchange Commission, Washington, D.C. 20549, in accordance with Rule 0-3
of the General Rules and Regulations under the Act. The information
contained in or filed with the form will be made a matter of public
record in the Commission files.
2
3. A manually signed copy of the form and amendments thereto shall be filed
with each national securities exchange on which any class of securities
of the registrant is registered.
4. Amendments to the notifications must also be filed on form 12b-25 but
need not restate information that has been correctly furnished. The form
shall be clearly identified as an amended notification.
5. ELECTRONIC FILERS. This form shall not be used by electronic filers
unable to timely file a report solely due to electronic difficulties.
Filers unable to submit a report within the time period prescribed due
to difficulties in electronic filing should comply with either Rule 201
or Rule 202 of Regulation S-T (ss.232.201 or ss.232.202 of this chapter)
or apply for an adjustment in filing date pursuant to Rule 13(b) of
Regulation S-T (ss.232.13(b) of this chapter).